Turning Scientific Promise into Meaningful Innovation
We make the difference for underserved neurological and rare disease communities around the world.
OUR VALUES
Inspired by the patients and families who count on us
Acadians dedicate their work to advancing therapies for underserved patients.
Solutions for the underservedStart with them
We put underserved patients first. Their needs guide every direction we make, because what matters to them, matters most to us.
Insight-led innovationListen to learn
We stay curious. Drawing on insights from patients, partners and each other, we take smarter, more compassionate approaches to advance care.
Enduring leadershipSee the promise
We see potential where others don’t. With bold science and a shared vision, we take on tough challenges because breakthroughs require courage.
Advancing careMake it happen
We go all in. We move forward together and show up with care, because people count on us.
OUR PASSIONTackling complex care areas with innovative medicines
Learn More About Our Medicines Acadia is advancing treatment in neurological disorders and rare diseases with novel therapies that redefine care for patients and families with few or no other options.
Our therapeutic areas
01Parkinson’s disease psychosis
PDP is a non-motor symptom impacting around half of people with Parkinson’s over the course of their disease.
02Rett syndrome
Rett Syndrome is a rare genetic neurological and developmental disorder that leads to problems with movement, coordination and communication.
03Alzheimer’s disease psychosis
Studies suggest that approximately 30 percent of patients diagnosed with Alzheimer’s disease have psychosis.
Careers
We are boldly pushing for brighter futures for those living with neurological disorders and rare diseases. Join us and be their difference.
Medical Hub
Our medical affairs team is committed to providing U.S. healthcare professionals with accurate and current scientific information about Acadia products.
For Partners
We can't create life-changing medicines alone. We actively seek partnerships and collaborations that drive therapeutic advancements forward for patients and their families.